Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Prudential plc (PUKPF)
London, GB
Prudential plc, operating through its subsidiaries, delivers a broad spectrum of financial solutions, with a core focus on life and health coverage, retirement planning, and investment management for individuals across Asia and Africa. Its offerings encompass health and protection policies, alongside diverse savings products like participating, unit-linked, and traditional options. The company also provides specific insurance against common critical illnesses such as cancer, stroke, and heart attacks, as well as protection from tropical diseases including dengue, malaria, and measles. For its asset management division, Prudential manages investments for both institutional and individual clients, employing various strategies across equities, fixed income, multi-asset, quantitative, and alternative portfolios. These products and services are distributed via a multi-channel network that includes its agency sales force, partnerships with banks, and independent brokers. The company, founded in 1848, is headquartered in London, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -11.80% | -11.80% | +14.06% | +14.06% | +32.34% | +4.57% | -33.95% | -30.56% | +108.82% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Insurance - Life: +10.6%+248.1% ★ Q4'25: +249.8% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%+83.3% ★ Q4'25: +377.3% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%+10.0% Q4'25: +9.8% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%+18.5% ★ Q4'25: +21.7% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%+22.1% ★ Q4'25: +58.0% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%+27.8% Q4'25: -6.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×1.15× Q4'25: 0.45× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
27.95B
est: 48.86B (-42.8%)
|
58.41B
est: 43.65B (+33.8%)
|
65.12B
est: 53.02B (+22.8%)
|
20.93B
est: 54.32B (-61.5%)
|
70.76B
est: 62.78B (+12.7%)
|
36.25B
est: 34.12B (+6.2%)
|
26.50B
est: 25.18B (+5.3%)
|
-27.59B
est: 24.47B (-212.7%)
|
11.97B
est: 25.51B (-53.1%)
|
8.14B
est: 3.84B (+112.1%)
|
28.33B
est: 6.56B (+332.2%)
|
6.76B
3.68B – 9.84B
+3.1% YoY
|
7.24B
4.01B – 10.47B
+7.1% YoY
|
9.11B
5.00B – 13.21B
+25.8% YoY
|
5.71B
3.14B – 8.28B
-37.3% YoY
|
3.82B
2.10B – 5.55B
-33.0% YoY
|
| EBITDA |
—
est: 8.11B (-100.0%)
|
—
est: 7.25B (-100.0%)
|
—
est: 8.80B (-100.0%)
|
—
est: 9.02B (-100.0%)
|
—
est: 10.42B (-100.0%)
|
3.44B
est: 5.66B (-39.2%)
|
2.94B
est: 4.18B (-29.6%)
|
-229.75M
est: 4.06B (-105.7%)
|
3.06B
est: 4.24B (-27.8%)
|
2.93B
est: 705.98M (+315.5%)
|
5.23B
est: 1.21B (+333.7%)
|
1.24B
677.82M – 1.81B
+3.1% YoY
|
1.33B
737.34M – 1.93B
+7.1% YoY
|
1.68B
920.59M – 2.43B
+25.8% YoY
|
1.05B
577.09M – 1.52B
-37.3% YoY
|
703.72M
386.64M – 1.02B
-33.0% YoY
|
| EBIT |
36.02B
est: 7.86B (+358.4%)
|
3.25B
est: 7.02B (-53.7%)
|
77.54B
est: 8.52B (+809.6%)
|
25.00B
est: 8.73B (+186.2%)
|
66.86B
est: 10.09B (+562.4%)
|
3.22B
est: 5.49B (-41.2%)
|
2.94B
est: 4.05B (-27.3%)
|
-229.75M
est: 3.93B (-105.8%)
|
2.54B
est: 4.10B (-38.2%)
|
3.12B
est: 690.39M (+352.5%)
|
5.23B
est: 1.18B (+343.5%)
|
1.22B
662.85M – 1.77B
+3.1% YoY
|
1.30B
721.06M – 1.88B
+7.1% YoY
|
1.64B
900.27M – 2.38B
+25.8% YoY
|
1.03B
564.35M – 1.49B
-37.3% YoY
|
688.18M
378.11M – 998.26M
-33.0% YoY
|
| Net Income |
3.82B
est: 3.65B (+4.7%)
|
2.37B
est: 3.34B (-29.1%)
|
2.39B
est: 4.30B (-44.4%)
|
3.15B
est: 4.13B (-23.6%)
|
591.08M
est: 4.39B (-86.5%)
|
2.12B
est: 4.42B (-52.1%)
|
-2.04B
est: 2.79B (-173.2%)
|
-1.01B
est: 2.14B (-147.2%)
|
1.70B
est: 2.19B (-22.2%)
|
2.29B
est: 2.70B (-15.5%)
|
4.06B
est: 3.56B (+14.2%)
|
4.25B
1.76B – 6.74B
+19.4% YoY
|
5.00B
2.07B – 7.93B
+17.7% YoY
|
5.51B
2.28B – 8.73B
+10.1% YoY
|
5.94B
2.46B – 9.42B
+8.0% YoY
|
6.85B
2.84B – 10.86B
+15.2% YoY
|
| SGA |
3.21B
est: 711.34M (+351.5%)
|
4.40B
est: 635.50M (+591.8%)
|
4.68B
est: 771.89M (+506.2%)
|
2.26B
est: 790.84M (+186.2%)
|
3.79B
est: 913.92M (+314.6%)
|
2.43B
est: 496.67M (+389.9%)
|
3.13B
est: 366.53M (+753.4%)
|
3.10B
est: 356.27M (+770.1%)
|
—
est: 371.41M (-100.0%)
|
—
est: 4.35M (-100.0%)
|
—
est: 7.43M (-100.0%)
|
7.67M
4.18M – 11.16M
+3.1% YoY
|
8.21M
4.54M – 11.88M
+7.1% YoY
|
10.33M
5.67M – 14.98M
+25.8% YoY
|
6.47M
3.56M – 9.39M
-37.3% YoY
|
4.34M
2.38M – 6.29M
-33.0% YoY
|
| EPS |
0.68
est: 1.34 (-49.3%)
|
0.61
est: 1.23 (-50.3%)
|
0.70
est: 1.58 (-55.7%)
|
0.65
est: 1.52 (-57.2%)
|
0.57
est: 1.61 (-64.7%)
|
1.63
est: 1.62 (+0.3%)
|
-1.55
est: 1.03 (-251.2%)
|
-0.74
est: 0.79 (-194.3%)
|
1.24
est: 0.80 (+54.2%)
|
0.84
est: 0.78 (+7.9%)
|
1.54
est: 1.02 (+50.5%)
|
1.22
0.51 – 1.94
+19.4% YoY
|
1.44
0.60 – 2.28
+17.7% YoY
|
1.58
0.66 – 2.51
+10.1% YoY
|
1.71
0.71 – 2.71
+8.0% YoY
|
1.97
0.82 – 3.12
+15.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 3/5 | 5/5 | 4/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-07 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1)Names of reporting persons. BlackRock, Inc. | 278.93M | 10.10% | 248.32M | — | 278.93M | — | HC | Delaware | 2022-07-08 | ↗ |
| 2 | BlackRock for purposes of Schedule 13G filings. | 160.16M | 6.33% | 160.16M | — | 160.16M | — | HC | Delaware | 2010-01-29 | ↗ |
| 3 | Capital Research Global Investors ** | 148.18M | 5.70% | 148.18M | — | 148.18M | — | IA | Delaware | 2018-02-14 | ↗ |
| 4 | BlackRock, Inc. | 142.39M | 5.60% | 128.46M | — | 142.39M | — | HC | Delaware | 2014-02-03 | ↗ |
| 5 | The Vanguard Group Inc. | 31.16M | 10.15% | 142.39M | — | 156.87M | — | IA | Delaware | 2017-01-25 | ↗ |
| 6 | Persons. | 16.34M | 18.60% | — | — | — | — | OO | England and Wales | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anil Wadhwani | Chief Executive Officer & Executive Director | 5M | male |
| Anette Bronder | Chief Technology & Operations Officer | — | female |
| Avnish Kalra | Chief Risk & Compliance Officer | — | male |
| Benjamin James Bulmer | Chief Financial Officer | — | male |
| Catherine Chia | Chief Human Resources Officer | — | female |
| Ciaran Mulligan | Head of Manager Oversight for Portfolio Management Group | — | — |
| Patrick Bowes | Head of Investor Relations | — | male |
| Rebecca Wyatt | Chief of Financial & Capital Reporting | — | — |
| Allen Thai | Chief Representative of Myanmar Office | — | male |
| Thean Oon Tan | Regional CEO of Singapore, Thailand, Vietnam & Partnership Distribution | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PUKPF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
